These findings are also intriguing considering the increased population of PD1+/CD8 TLs we found in MEKi+BCL-XLi treated tumors, which has been reported to correlate with exhausted signature and poor clinical outcome in HCC.54 Here, CD8A is linked to hepatocellular carcinoma.